Rafael Holdings, Inc. Asset Resilience Ratio

Latest as of January 2026: 38.04%

Rafael Holdings, Inc. asset resilience ratio. Rafael Holdings, Inc. (RFL) has an Asset Resilience Ratio of 38.04% as of January 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of Rafael Holdings, Inc. to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$37.78 Million
Cash + Short-term Investments

Total Assets

$99.31 Million
All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio of Rafael Holdings, Inc. (2016–2025)

Asset resilience ratio of Rafael Holdings, Inc. from 2016 to 2025. This chart shows how Rafael Holdings, Inc.'s Asset Resilience Ratio has changed over time. Read RFL total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Rafael Holdings, Inc.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Rafael Holdings, Inc. (RFL) total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $37.78 Million 38.04%
Short-term Investments $0.00 0%
Total Liquid Assets $37.78 Million 38.04%

Asset Resilience Insights

  • Very High Liquidity: Rafael Holdings, Inc. maintains exceptional liquid asset reserves at 38.04% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Rafael Holdings, Inc. Industry Peers by Asset Resilience Ratio

Compare Rafael Holdings, Inc.'s asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
CELLN.TELEC.UNSP.ADR/1/2
F:4720
Real Estate Services 0.01%
Plaza S.A
SN:MALLPLAZA
Real Estate Services 0.04%
CPI Property Group S.A
F:O5G
Real Estate Services 0.33%
Olav Thon Eien
OL:OLT
Real Estate Services 0.20%
Mainstreet Equity Corp.
TO:MEQ
Real Estate Services 3.08%
Argo Properties NV
TA:ARGO
Real Estate Services 0.12%
AB Sagax (publ)
ST:SAGA-D
Real Estate Services 2.88%
Jereissati Participações S.A.
SA:IGTI3
Real Estate Services 22.64%

Rafael Holdings, Inc. Asset Resilience Ratio by Year (2016–2025)

Rafael Holdings, Inc. asset resilience ratio by year from 2016 to 2025. The table below shows the annual Asset Resilience Ratio data for Rafael Holdings, Inc..

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-07-31 46.24% $52.77 Million $114.11 Million -21.85pp
2024-07-31 68.10% $65.94 Million $96.83 Million -12.35pp
2023-07-31 80.45% $79.51 Million $98.83 Million +27.00pp
2022-07-31 53.44% $63.23 Million $118.32 Million +47.97pp
2021-07-31 5.47% $8.43 Million $154.06 Million +0.92pp
2020-07-31 4.55% $6.21 Million $136.35 Million -3.91pp
2019-07-31 8.46% $12.02 Million $142.14 Million -26.18pp
2018-07-31 34.64% $40.50 Million $116.92 Million +21.01pp
2017-07-31 13.64% $11.76 Million $86.20 Million +10.00pp
2016-07-31 3.64% $2.34 Million $64.31 Million --
pp = percentage points

About Rafael Holdings, Inc.

NYSE:RFL USA Real Estate Services
Market Cap
$54.81 Million
Market Cap Rank
#21364 Global
#4795 in USA
Share Price
$1.07
Change (1 day)
-0.93%
52-Week Range
$1.00 - $3.78
All Time High
$63.59
About

Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and medical devices in the United States and Israel. It operates in three segments, Healthcare, Infusion Technology, and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells… Read more